Bloomberg.com reports that Cytocore, Inc., has developped a new cervical cancer screening test that decreases the risk of false negatives.
SoftPAP, as the test is called, collects more cell specimens, making the likelihood of getting false tests results less likely.
The test also decreases women's chances of bleeding and spotting as a result of having a Pap smear. It is slated to be released onto the market later this year.
Get answers from our experts and community members.
View all questions >
By using this service, you accept our Terms of Use. Please read them. The consumer health information on HerpesConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2008. The HealthCentral Network, Inc. All rights reserved.
 | We comply with the HONcode standard for trustworthy health information: verify here. |
